The announcement comes as doctors battle an Ebola outbreak in Africa.
The current outbreak, also known as hemorrhagic fever, involves the Bundibugyo strain.
“WHO expert groups today recommend that two vaccine candidates be added to the clinical trial developed in October against the Bundibugyo virus, which is currently raging in Congo-Kinshasa,” WHO Director-General Tedros Adhanom Ghebreyesus told reporters on Wednesday.
The two vaccine candidates have been developed specifically for the Bundibugyo virus. One was developed by the University of Oxford together with the Serum Institute of India, and the other by Moderna.
According to the Africa Centres for Disease Control and Prevention (CDC), 5,300 people have died in the ongoing outbreak. Most of the deaths have been recorded in Congo-Kinshasa.
What do you think?